These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease. van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007 [TBL] [Abstract][Full Text] [Related]
9. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms. Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781 [TBL] [Abstract][Full Text] [Related]
10. Patients with acute pancreatitis complicated by organ failure show highly aberrant monocyte signaling profiles assessed by phospho-specific flow cytometry. Oiva J; Mustonen H; Kylänpää ML; Kyhälä L; Alanärä T; Aittomäki S; Siitonen S; Kemppainen E; Puolakkainen P; Repo H Crit Care Med; 2010 Aug; 38(8):1702-8. PubMed ID: 20512034 [TBL] [Abstract][Full Text] [Related]
11. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043 [TBL] [Abstract][Full Text] [Related]
12. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052 [TBL] [Abstract][Full Text] [Related]
13. CARD15 frameshift mutation in patients with CROHN disease is associated with immune dysregulation. Halme L; Turunen U; Paavola-Sakki P; Heliö T; Lappalainen M; Färkkilä M; Kontula K; Repo H Scand J Gastroenterol; 2004 Dec; 39(12):1243-9. PubMed ID: 15743002 [TBL] [Abstract][Full Text] [Related]
14. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952 [TBL] [Abstract][Full Text] [Related]
15. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice. Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073 [TBL] [Abstract][Full Text] [Related]
17. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants. Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775 [TBL] [Abstract][Full Text] [Related]
18. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta. Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816 [TBL] [Abstract][Full Text] [Related]
19. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease. Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524 [TBL] [Abstract][Full Text] [Related]
20. The NOD2-RICK complex signals from the plasma membrane. Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]